Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Stephen A. Brunton & D. Kyle Hogarth. (2023) Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns. Postgraduate Medicine 0:0, pages 1-19.
Read now
Read now
Samy Suissa, Sophie Dell’Aniello & Pierre Ernst. (2022) Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 133-141.
Read now
Read now
Articles from other publishers (2)
Dave Singh, Klaus F. Rabe, Fernando J. Martinez, Matthias Krüll, Martin Jenkins, Mehul Patel & Paul Dorinsky. (2022) Relationship between prior inhaled corticosteroid use and benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study. Respiratory Medicine 197, pages 106857.
Crossref
Crossref
Robert A. Wise, Benjamin M. Scirica, Deepak L. Bhatt, Sami Z. Daoud, Ferran Chuecos, Esther Garcia Gil & Kenneth R. Chapman. (2021) Efficacy of Aclidinium Bromide According to Baseline Therapy: Post-Hoc Analysis of ASCENT-COPD Randomized Trial. Advances in Therapy 38:10, pages 5381-5397.
Crossref
Crossref